Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

US green light for Teva birth control pill
Pharma Times, UK
Tuesday, April 2, 2013 - 10:09am
tags:
Teva, FDA, birth control pill, Quartette
Many Docs & Researchers Know Little About The Sunshine Rule
Pharmalot
Tuesday, April 2, 2013 - 10:08am
tags:
physicians, Physician Payment Sunshine Act
Apricus Biosciences announces sale of non-core assets
Yahoo/Fly on the Wall
Tuesday, April 2, 2013 - 10:07am
tags:
Apricus Biosciences, NitroMist, Biocodex, Totect
SciClone Q4 Net Drops Steeply
Motley Fool
Tuesday, April 2, 2013 - 10:05am
tags:
earnings, SciClone Pharmaceuticals
Optimer Said to Draw Takeover Interest From Glaxo, Astellas
Bloomberg
Tuesday, April 2, 2013 - 10:04am
tags:
GSK, Astellas, M&A, Optimer Pharmaceuticals, AstraZeneca, Cubist Pharmaceuticals
Clavis Pharma May Close or Be Taken Over After Failed Drug Trial
Bloomberg
Tuesday, April 2, 2013 - 10:03am
tags:
Clavis Pharma, leukemia, elacytarabine
Ampio's Eye Drug Trial Design Won't Pass FDA Muster
TheStreet.com
Tuesday, April 2, 2013 - 9:56am
tags:
FDA, clinical trials, Ampio Pharmaceuticals, Optina, diabetic macular edema
Potential Lilly Investment Would Further Expand Indianapolis Insulin Manufacturing Operations
Yahoo
Tuesday, April 2, 2013 - 9:55am
tags:
Eli Lilly, drug manufacturing, insulin
AstraZeneca says Pulmicort Respules patent ruled invalid
Yahoo/Fly on the Wall
Tuesday, April 2, 2013 - 9:55am
tags:
Pulmicort, patents, AstraZeneca
Will Novartis decision impact U.S. drug prices?
Marketwatch
Tuesday, April 2, 2013 - 9:53am
tags:
drug pricing, generics, patents, Glivec, Novartis, India
Johnson & Johnson's New Diabetes Drug And Its Competitors
Seeking Alpha
Tuesday, April 2, 2013 - 9:52am
tags:
JNJ, diabetes, Invokana, Merck, Januvia, Byetta, Bristol-Myers Squibb
GlaxoSmithKline: FDA recommends removing warning statements on NRT products
The Fly on the Wall
Tuesday, April 2, 2013 - 9:50am
tags:
FDA, GSK, NRT, smoking cessation
Tecfidera Raises The Bar For Biogen Idec
Seeking Alpha
Tuesday, April 2, 2013 - 9:48am
tags:
MS, multiple sclerosis, Biogen Idec, Tecfidera, Novartis, Sanofi
Should Anti-Obesity Drug Company Stocks Trade In Tandem?
Seeking Alpha
Monday, April 1, 2013 - 11:56am
tags:
Vivus, Orexigen, Arena Pharmaceuticals, obesity
Biotech M&A deals dominate key Q1 metric
Fierce Biotech
Monday, April 1, 2013 - 11:22am
tags:
M&A, biotech
FDA saw early reports of severe Omontys reactions: WSJ
Fierce Pharma
Monday, April 1, 2013 - 11:20am
tags:
FDA, Omontys, Affymax, anemia, Takeda
Where Is Exelixis In The Cancer Therapeutics Market?
Seeking Alpha
Monday, April 1, 2013 - 11:01am
tags:
Exelixis, cabozantinib, Cometriq, cancer
BioMarin submits CTA for BMN-190 for Batten disease
Yahoo/Fly on the Wall
Monday, April 1, 2013 - 10:59am
tags:
Biomarin, BMN-190, Batten disease
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Yahoo
Monday, April 1, 2013 - 10:58am
tags:
ARQ092, Daiichi Sankyo, Arqule, akt protein inhibitor, cancer
BioCryst's shares spike on hope that flu drug can rise from the grave
Fierce Biotech
Monday, April 1, 2013 - 10:55am
tags:
Biocryst, Flu, influenza, peramivir

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.